Drug profile

The FDA adverse-event record for Carprofen (Unknown)

487 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Carprofen (Unknown). See the species affected, top reactions, and outcomes below.

487
adverse-event reports
6.6%
death-coded share
Dog
most-reported species
106
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
487
Total Reports
32
Deaths Reported
6.6%
Death Rate

Active Ingredients

Carprofen (Unknown)

Administration Routes

OralUnknownParenteralSubcutaneousRectal

Species Affected

Dog 487

Most Affected Breeds

Retriever - Labrador 103
Shepherd Dog - German 25
Retriever - Golden 24
Pit Bull 24
Crossbred Canine/dog 21
Shepherd Dog - Australian 17
Beagle 14
Shih Tzu 12
Dachshund (unspecified) 11
Boxer (German Boxer) 10

Most Reported Reactions

Vomiting 106
Emesis 74
Lethargy (see also Central nervous system depression in 'Neurological') 54
Diarrhoea 49
Lack of efficacy - NOS 48
Elevated alanine aminotransferase (ALT) 31
Seizure NOS 29
Other abnormal test result NOS 28
Not eating 24
Elevated serum alkaline phosphatase (SAP) 23
Anorexia 22
Death by euthanasia 17

Outcome Breakdown

Recovered/Normal
179 (36.8%)
Outcome Unknown
156 (32.0%)
Ongoing
103 (21.1%)
Recovered with Sequela
17 (3.5%)
Euthanized
17 (3.5%)
Died
15 (3.1%)

Carprofen (Unknown) Adverse Event Insights

487 reports name Carprofen (Unknown); 32 recorded a death outcome (6.6% of reported events, not a population-level mortality rate). Active ingredient: Carprofen (Unknown). Administration routes: Oral, Unknown, Parenteral, Subcutaneous.

By species: Dog (487 reports). By breed: Retriever - Labrador (103), Shepherd Dog - German (25), Retriever - Golden (24).

Leading clinical signs: Vomiting (106), Emesis (74), Lethargy (see also Central nervous system depression in 'Neurological') (54), Diarrhoea (49). Outcome, 487 coded reports: Recovered/Normal leads at 36.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.